Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional Laser

SIMPLE SUMMARY: The use of immune checkpoint inhibitors (ICI) is expanding with the approval for locally advanced and metastasizing keratinocyte carcinoma. Most cases, however, are non-aggressive. Systemic therapy remains limited by severe side effects. Local administration could broaden ICI, but an...

Descripción completa

Detalles Bibliográficos
Autores principales: Omland, Silje Haukali, Ejlertsen, Jacob Secher, Krustrup, Dorrit, Christensen, Rikke Louise, Svane, Inge Marie, Olesen, Uffe Hoegh, Hædersdal, Merete
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738516/
https://www.ncbi.nlm.nih.gov/pubmed/36497301
http://dx.doi.org/10.3390/cancers14235815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738516/
https://www.ncbi.nlm.nih.gov/pubmed/36497301
http://dx.doi.org/10.3390/cancers14235815

Ejemplares similares